StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) income statement

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2024

Profitability, TTM

Gross margin
–
Operating margin
-2490.3%
Net margin
-4452.1%
Return on equity, FY2023
129.1%

Financial strength

Current ratio
0.00
Debt to equity
-0.02
Debt to assets
5.0%
Cash to current liabilities
0.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?